
X
Genmab axes development of AXL-targeting cancer drug enapotamab vedotin
https://pharmaphorum.com/news/genmab-axes-development-axl-targeting-cancer-drug-enapotamab-vedotin/
Speculation mounts that J&J will bid for R&D partner
Development partner Genmab says drug approved in relapsed disease.